Tag: entrepreneurs
-
Google to Partner with, Finance DNA Sequencing Data Company
DNAnexus Inc., a DNA data management and analysis company in Mountain View, California, says it will collaborate with Google Inc. to provide access to its archive of publicly available DNA data. Also today, DNAnexus announced it has secured $15 million in second-round equity funding from a syndicate led by Google Ventures and life sciences venture…
-
SBIR Grant Awarded to Rutgers Spin-Off for Biopsy Imaging
National Institutes of Health (NIH) has awarded a spin-off company from Rutgers University in New Jersey a small-business grant to develop a quick and economical analysis of tissue from breast cancer biopsies. The grant of $207,000 to Ibris Inc. of Piscataway, New Jersey, was made through through NIH’s Small Business Innovation Research (SBIR) program. Ibris…
-
University of Michigan to Invest in Campus Start-Ups
University of Michigan president Mary Sue Coleman said Wednesday that the university would begin investing directly in new businesses created from research conducted on its campus. The program, called Michigan Investment in New Technology Startups (MINTS), would provide up to $25 million in early-stage capital over the next 10 years. The university says eligible start-ups…
-
Spanish Institute Spin-Off to Develop Cancer Diagnostics
A new company spun off from the Institute of Research in Biomedicine in Barcelona, Spain (IRB Barcelona), will develop a diagnostic kit and treatments for breast cancer metastasis. Supragen is founded and commercializes research by Roger Gomis (pictured right), group leader of IRB Barcelona’s Growth Control and Cancer Metastasis lab. The lab investigates growth factors,…
-
Small Business Grant Awarded for Bone Marrow Protection Drug
A company in Chapel Hill, North Carolina has received a $3 million grant from NIH to commercialize a therapy to protect bone marrow in cancer patients against damage from chemo and radiation therapy. G-Zero Therapeutics received the Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases. The award to…
-
Commercial Production Begins for New Lithium Process
Simbol Materials, a three year-old company in Pleasanton, California, says it will begin today commercial production of a pure form of lithium carbonate for electric vehicle batteries and other energy storage devices. The company’s process, developed out of research conducted at and licensed from Lawrence Livermore National Lab, also produces manganese and zinc. The production…
-
Copper Nanofilm Can Replace Rare Earth in Digital Displays
Research chemists at Duke University in Durham, North Carolina have developed a film made of copper nanowires that could replace expensive rare earths now used in digital displays. The discovery by Duke chemistry professor Ben Wiley and grad student Aaron Rathmell appears online in the journal Advanced Materials (paid subscription required). Wiley has also started…
-
Kauffman Global Scholars Program Applications Now Open
The Global Scholars Program, a six-month training program on entrepreneurship offered by the Ewing Marion Kauffman Foundation in Kansas City, Missouri is now accepting applications for 2012. The foundation encourages recent (since 2009) undergraduate or graduate degree recipients with ideas for new businesses in the natural or physical sciences, technology, and engineering fields. Applicants need…
-
Mapping Project to Find Innovation, Entrepreneurial Networks
The University of Maryland in College Park will develop analytical mapping tools that identify innovation and entrepreneurial networks, and help spot opportunities for new business collaborations. The project, funded by part of a $500,000 grant from U.S. Department of Commerce, is based on research conducted by a Maryland doctoral candidate in urban and regional planning.…
-
University Spin-Off Begins Trial of Stem Cell ALS Treatment
A technology developed at Tel Aviv University in Israel and licensed to a spin-off company invokes the potential of bone-marrow stem cells as treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. A clinical trial, now in Israel and later in the U.S., to test the discovery is recruiting participants. The technology…